Bristol Myers Squibb Goodwill and Intangible Assets 2010-2024 | BMY

Bristol Myers Squibb goodwill and intangible assets for the quarter ending September 30, 2024 were $48.715B, a 2.76% decline year-over-year.

  • Bristol Myers Squibb goodwill and intangible assets for 2023 were $48.241B, a 15.38% decline from 2022.
  • Bristol Myers Squibb goodwill and intangible assets for 2022 were $57.008B, a 9.55% decline from 2021.
  • Bristol Myers Squibb goodwill and intangible assets for 2021 were $63.029B, a 14.58% decline from 2020.

Bristol Myers Squibb Goodwill and Intangible Assets 2010-2024 | BMY

  • Bristol Myers Squibb goodwill and intangible assets for 2023 were $48.241B, a 15.38% decline from 2022.
  • Bristol Myers Squibb goodwill and intangible assets for 2022 were $57.008B, a 9.55% decline from 2021.
  • Bristol Myers Squibb goodwill and intangible assets for 2021 were $63.029B, a 14.58% decline from 2020.